A Therapeutic Index That Predicts the Individual Effects of Prednisone in Patients With Cirrhosis
- 1 January 1985
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 88 (1), 156-165
- https://doi.org/10.1016/s0016-5085(85)80148-7
Abstract
No abstract availableKeywords
Funding Information
- Sundhed og Sygdom, Det Frie Forskningsråd
This publication has 20 references indexed in Scilit:
- Prednisone and chronic liver disease. II. Clinical versus morphological criteria for selection of patients for prednisone treatmentLiver International, 2008
- Prognostic Factors in Cirrhosis Identified by Cox's Regression ModelHepatology, 2007
- Conversion of Micronodular Cirrhosis into Macronodular CirrhosisHepatology, 2007
- Prednisolone in HBsAg-positive chronic active hepatitis: Histologic evaluation in a controlled prospective studyHepatology, 1982
- Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic markerLiver International, 1982
- Clinical relevance of restrictive morphological criteria for the diagnosis of cirrhosis in liver biopsiesLiver International, 1981
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- Sex, Ascites and Alcoholism in Survival of Patients with CirrhosisNew England Journal of Medicine, 1974
- ANTINUCLEAR-FACTOR SERUM (HOMOGENEOUS): AN INTERNATIONAL COLLABORATIVE STUDY OF THE PROPOSED RESEARCH STANDARD 66/233Annals of the New York Academy of Sciences, 1971
- Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQJM: An International Journal of Medicine, 1971